Key result
Pulsed electrostatic field therapy improved circulating NO levels, blood pressure, heart rate, metabolic profile, and perceived quality of life in patients with T2DM and chronic kidney disease.
Why the study?
Microangiopathy impairs organ and tissue integrity and reduces perceived quality of life in type II diabetes mellitus, prompting evaluation of pulsed electrostatic fields on peripheral tissue perfusion.
Does pulsed electrostatic field (PESF) improve circulating NO levels and quality of life in patients with T2DM and chronic kidney disease?
Observational
Does pulsed electrostatic field (PESF) improve circulating NO levels and quality of life in patients with T2DM and chronic kidney disease?
Pulsed electrostatic fields may improve peripheral perfusion markers, metabolic profile, and quality of life in patients with T2DM and chronic kidney disease.
PESF-associated gains in T2DM-CKD should not change practice; hypothesis-generating and needs RCTs.
Microangiopathy compromises the structural and functional integrity of organs and tissues in patients with type II diabetes mellitus (T2DM) negatively affecting the perceived quality of life. Nitric oxide (NO) is a multifunctional signalling molecule, acting as a vasodilator, neurotransmitter, and modulator of inflammatory processes. Patients with type II diabetes mellitus and chronic kidney disease, controlled from glycaemic status, were treated or not with pulsed electrostatic field (PESF) cycles to evaluate effect on the perfusion of peripheral tissues. Everyone was monitored for the metabolic profile, and we tested circulating NO with a commercial enzyme immunoassay kit. In addition, we tested the perceived quality of life of patients before/after a PESF cycle using a questionnaire. Patients treated with PESF were improved circulating NO levels, significant changes in systolic and diastolic blood pressure, heart rate and were more homogeneous for their metabolic profile. The questionnaire showed also a marked improvement in the perceived quality of life. The use of pulsed electrostatic fields has allowed us to observe an improvement in the metabolic, psychological, and clinical profile in patients with T2DM and chronic kidney disease whose pathological profile is strongly compromised.
No takes yet. Share an insight, caveat, or question.
Liani et al. (2022) conducted an observational in Type II diabetes mellitus and chronic kidney disease. Pulsed electrostatic field (PESF) cycles vs. No PESF treatment was evaluated on Circulating NO levels, metabolic profile, and perceived quality of life. Pulsed electrostatic field therapy improved circulating NO levels, blood pressure, heart rate, metabolic profile, and perceived quality of life in patients with T2DM and chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: